Barclays’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Barclays’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-484	Closed	-$48K	–	7476
2015 Q1	$48K	Sell	484 -45	-9%	-$3K	﹤0.01%	5318
2014 Q4	$28K	Sell	529 -361	-41%	-$10.6K	﹤0.01%	6125
2014 Q3	$22K	Sell	890 -3,031	-77%	-$64.5K	﹤0.01%	6438
2014 Q2	$86K	Buy	3,921 +3,701	+1,682%	+$81K	﹤0.01%	5541
2014 Q1	$7K	Buy	+220	New	+$5.91K	﹤0.01%	7113

Barclays's ASPX Position: Q2 2015 in Review

Barclays sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 484 shares — an estimated $48K sold.

Barclays first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $86K in Q2 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Barclays reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Barclays sold 484 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $48K.
Barclays first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
Barclays's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $86K in Q2 2014.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.